Avrobio Inc Reports Results For The Quarter Ended In September: Earnings Summary

Tectonic Therapeutic

08/11/2022 12:55

* AVROBIO Inc  AVRO.OQ  reported a quarterly adjusted loss
of 52
cents​​ per share for the quarter ended in September. The mean
expectation of eight analysts for the quarter was for a loss
of 55 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * AVROBIO Inc's reported EPS for the quarter was a loss
of 52
cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.3%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * AVROBIO Inc shares had risen by 2.7% this quarter and
lost 82.9%
so far this year.
    * The company reported a quarterly loss of $22.97 million.
    * Wall Street's median 12-month price target for AVROBIO Inc
is
$4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 12:55 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.55          -0.52          Beat
 Jun. 30 2022      -0.57          -0.64          Missed
 Mar. 31 2022      -0.59          -0.68          Missed
 Dec. 31 2021      -0.74          -0.65          Beat